Clinical genitourinary cancer
Journal
Overview
publication venue for
-
Adenocarcinoma of unknown primary in a 20-year-old African American male.
2009
-
Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study..
22.
2024
-
Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With Metastatic Castration-Resistant Prostate Cancer (mCRPC): A SPARTACUSS-Meet-URO 26 Real-World Study..
22.
2024
-
A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder..
22.
2024
-
Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS-Meet-URO 26 Study.
2024
-
Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer..
22.
2024
-
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites.
2023
-
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy.
2023
-
Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node Invasion.
2023
-
Intermediate Grade Prostate Cancer and Risk for Adverse Pathology Radical Prostatectomy: Implications for Partial Gland Ablation Case Selection.
2023
-
Global Trends of Prostate Cancer by Age, and Their Associations With Gross Domestic Product (GDP), Human Development Index (HDI), Smoking, and Alcohol Drinking..
21.
2023
-
Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy..
21.
2023
-
Safety Profile of Ipatasertib Plus Abiraterone vs Placebo Plus Abiraterone in Metastatic Castration-resistant Prostate Cancer.
2023
-
The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis..
21.
2022
-
Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes.
2022
-
Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma..
21.
2022
-
Evolving Trends in the Management of Low-Risk Prostate Cancer.
2022
-
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy.
2022
-
Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors..
20.
2022
-
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients..
20.
2022
-
Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival..
20.
2022
-
Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal Cancer..
20.
2022
-
Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study.
2022
-
Sociodemographic Disparities in Access to Chemotherapy for Bladder Cancer.
2021
-
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy.
2021
-
Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.
2021
-
Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma..
20.
2021
-
Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients..
20.
2021
-
Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin..
20.
2021
-
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.
2021
-
Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma..
19.
2021
-
A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer.
2021
-
Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis..
19.
2021
-
Salvage Radical Prostatectomy: Baseline Prostate Cancer Characteristics and Survival Across SEER Registries..
19.
2021
-
Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic..
19.
2021
-
Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients..
19.
2021
-
Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma..
19.
2020
-
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC)..
19.
2020
-
Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities..
19.
2020
-
Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study..
18.
2020
-
Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma..
18.
2020
-
Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study..
18.
2020
-
Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience..
18.
2020
-
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma..
18.
2020
-
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study..
18.
2020
-
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States..
18.
2020
-
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities..
18.
2019
-
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality..
18.
2019
-
Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer..
18.
2019
-
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion..
18.
2019
-
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study..
18.
2019
-
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes..
18.
2019
-
Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy..
17.
2019
-
Association of Hyponatremia With Survival in Patients With Castration-resistant Prostate Cancer: A Clinical Commentary..
17.
2019
-
Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer..
17.
2019
-
Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors..
17.
2019
-
Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer..
17.
2019
-
Interobserver Agreement of the Estimated Contact Surface Area System for Renal Masses..
17.
2019
-
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy..
17.
2019
-
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma..
17.
2019
-
Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence"..
17.
2019
-
Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery..
17.
2019
-
COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma..
17.
2019
-
More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder..
17.
2018
-
Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?.
17.
2018
-
Rates of Positive Surgical Margins and Their Effect on Cancer-specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer..
17.
2018
-
Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma..
17.
2018
-
Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study..
17.
2018
-
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome..
16.
2018
-
Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer..
16.
2018
-
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer..
16.
2018
-
Location of Metastases in Contemporary Prostate Cancer Patients Affects Cancer-Specific Mortality..
16.
2018
-
Sunitinib in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to International Metastatic Renal Cell Carcinoma Database Consortium Risk Group..
16.
2018
-
Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program..
16.
2018
-
Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence..
16.
2018
-
Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score..
16.
2018
-
The Effect of Patient and Surgical Characteristics on Renal Function After Partial Nephrectomy..
16.
2017
-
Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer..
16.
2017
-
External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based Study.
2017
-
Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer.
2017
-
Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle-invasive Bladder Cancer.
2017
-
Clinical Outcomes of Patients With T1 Nested Variant of Urothelial Carcinoma Compared to Pure Urothelial Carcinoma of the Bladder.
2017
-
Long-Term Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma: A Pooled Analysis of Clinical Trials.
2017
-
Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma..
15.
2017
-
Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes..
15.
2017
-
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer..
15.
2017
-
Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial..
15.
2017
-
Germline Genetic Biomarkers of Sunitinib Efficacy in Advanced Renal Cell Carcinoma: Results From the RENAL EFFECT Trial..
15.
2017
-
Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy..
15.
2017
-
Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes..
15.
2016
-
Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients..
15.
2016
-
Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 Years..
15.
2016
-
Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy..
15.
2016
-
Incidence and Predictors of 30-Day Readmission After Robot-Assisted Radical Prostatectomy..
15.
2016
-
Weight Loss Following Radical Cystectomy for Bladder Cancer: Characterization and Effect on Survival..
15.
2016
-
Association of Aromatase With Bladder Cancer Stage and Long-Term Survival: New Insights Into the Hormonal Paradigm in Bladder Cancer..
15.
2016
-
Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials..
14.
2016
-
Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer..
14.
2016
-
Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma..
14.
2015
-
Incidence and Predictors of 30-Day Readmission in Patients Treated With Radical Cystectomy: A Single Center European Experience..
14.
2015
-
Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma..
14.
2015
-
Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma..
14.
2015
-
Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs..
14.
2015
-
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma..
14.
2015
-
Long-Term Safety With Axitinib in Previously Treated Patients With Metastatic Renal Cell Carcinoma..
13.
2015
-
Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors..
13.
2015
-
Genotype Correlations With Blood Pressure and Efficacy From a Randomized Phase III Trial of Second-Line Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma..
13.
2015
-
Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based study..
13.
2014
-
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer..
13.
2014
-
Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma..
13.
2014
-
Treatment patterns and costs for metastatic renal cell carcinoma patients with private insurance in the United States..
13.
2014
-
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design..
13.
2014
-
Safety and efficacy of targeted therapy for renal cell carcinoma with brain metastasis..
13.
2014
-
Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer..
12.
2014
-
Sequential targeted therapy after pazopanib therapy in patients with metastatic renal cell cancer: efficacy and toxicity..
12.
2014
-
Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis..
11.
2013
-
Long-term response to sunitinib therapy for metastatic renal cell carcinoma..
11.
2013
-
Five-year survival in patients with cytokine-refractory metastatic renal cell carcinoma treated with axitinib..
11.
2013
-
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy..
9.
2011
-
Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus Doxorubicin in the treatment of metastatic castration-resistant prostate cancer..
7.
2009
-
Arsenic trioxide in recurrent urothelial cancer: a cancer and leukemia group B phase II trial (CALGB 99903)..
7.
2009
-
Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research..
7.
2009
-
Phase I trial of sunitinib malate plus interferon-alpha for patients with metastatic renal cell carcinoma..
7.
2009
-
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004..
6.
2008
-
Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinoma..
6.
2008
-
Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design..
5.
2007
-
Development of an integrated prostate cancer research information system..
5.
2006
-
Prognostic Value of Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-analysis.
2020
-
Prognostic Value of Hemoglobin in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.
2019
-
Impact of Gender on Chemotherapeutic Response and Oncologic Outcomes in Patients Treated With Radical Cystectomy and Perioperative Chemotherapy for Bladder Cancer: A Systematic Review and Meta-Analysis.
2019
-
Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis.
2019
-
Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
2019
-
Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature.
2018
-
Chemotherapy for non-clear-cell renal cell carcinoma.
2006
-
Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
2006
-
Treatment Intensification With Novel Hormonal Therapy in Castration-Sensitive Prostate Cancer: Patient Identification and Clinical Rationale.
2024
-
A Systematic Review and Meta-Analysis of Clinicopathologic Factors Predicting Upper Urinary Tract Recurrence After Radical Cystectomy for Urothelial Bladder Cancer.
2022
-
Rosai-Dorfman Disease: Case Report of an Unusual Testicular Involvement and Review of Literature.
2019
-
Periostin: a novel prognostic and therapeutic target for genitourinary cancer?
2014
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)